MedTrace Logo

Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder

NCT01547702 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2014-03-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate, by way of randomized controlled trial, the effectiveness of a web-based, time-flexible, and teacher-directed "Teacher Help for ADHD" program in reducing the impact of ADHD symptoms in elementary students.

Conditions

  • Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

BEHAVIORAL

Teacher Help for ADHD

Teachers will review powerpoints other materials online and will have access to a study coach to assist with their understanding and practical application of the materials. Session descriptions follow: * Session 1: Provide information about ADHD characteristics, impact, diagnosis, etiology * Session 2: Help establish teacher's role; goal setting; introduce behaviour planning * Session 3: Help develop and implement behaviour program specific to the needs of students with Session 2 goals * Session 4: Help develop strategies re: classroom structure, work assignments, teacher-student relationship * Session 5: Help to use instructional interventions for ADHD * Session 6: Help to teach these students self-monitoring and self-evaluation skills; help teachers to evaluate progress, phase out behaviour program, and plan for relapses in unwanted behaviours

Sponsors & Collaborators

  • Dalhousie University

    lead OTHER

Principal Investigators

  • Penny V Corkum, PhD · Dalhousie University

  • Nezihe Elik, PhD · The Hospital for Sick Children

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01547702 on ClinicalTrials.gov